Ferric Carboxy Maltose

DRUG2 trials

Sponsors

Shield Therapeutics, Shahida Islam Medical Complex

Conditions

Anemia, Iron-DeficiencyCrohn's DiseaseInflammatory Bowel DiseasePostpartum Anaemia

Phase 3

Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia in IBD

CompletedNCT02680756

Shield TherapeuticsAnemia, Iron-Deficiency, Crohn's Disease, Inflammatory Bowel Disease

Start: 2016-01-31End: 2019-01-31Updated: 2020-11-02

Unknown Phase

Comparison of Oral vs Intravenous Iron Therapy for the Treatment of Postpartum Anemia

CompletedNCT07340450

Shahida Islam Medical ComplexPostpartum Anaemia

Start: 2025-02-18End: 2025-08-18Updated: 2026-01-14

Related Papers

Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial

Inflammatory Bowel Diseases2021-05-1430 citations

P420 Comparative efficacy and safety of oral ferric maltol in Inflammatory Bowel Disease patients with mild-to-moderate vs. more severe iron deficiency anaemia

Journal of Crohn s and Colitis2021-05-011 citations